Table 1.
Immunophenotype and cytogenetic/molecular characteristics of AML samples
AML1 | AML2 | AML3 | AML4 | AML5 | AML6 | AML7 | AML8 | |
---|---|---|---|---|---|---|---|---|
PB Blasts | 19% | 74% | 18% | 92% | 25% | * | 83% | 79% |
BM Blasts | 34% | 76% | 34% | 90% | 43% | * | 79% | 65% |
CD34 | + | − | + | − | − | − | + | − |
CD33 | + | + | + | + | + | + | + | + |
CD13 | + | + | + | Partial | + | + | + | |
CD117 | + | − | + | Partial | + | − | + | − |
CD45 | Dim + | Dim + | Dim + | Dim + | Dim + | + | Dim + | Dim + |
HLA-DR | + | + | + | + | + | + | + | |
Cytogenetics/Molecular | Complex | FLT3 +ve | Complex | t(9:11), Complex | NPM1 +ve | Diploid | inv(16) | Complex |
missing